208 related articles for article (PubMed ID: 6989000)
1. A computerized tube leukocyte adherence inhibition assay to detect antitumor immunity in early human cancer: a review of two years' experience.
Ayeni RO; Tataryn DN; MacFarlane JK; Thomson DM; Schwartz R
Surgery; 1980 Apr; 87(4):380-9. PubMed ID: 6989000
[TBL] [Abstract][Full Text] [Related]
2. Tube leukocyte adherence inhibition (LAI) assay in gastrointestinal (GIT) cancer.
Tataryn DN; MacFarlane JK; Murray D; Thomson DM
Cancer; 1979 Mar; 43(3):898-912. PubMed ID: 371789
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of tube leukocyte adherence inhibition (LAI) assay for breast, colorectal, stomach and pancreatic cancer.
MacFarlane JK; Thomson DM; Phelan K; Shenouda G; Scanzano R
Cancer; 1982 Mar; 49(6):1185-93. PubMed ID: 7037158
[TBL] [Abstract][Full Text] [Related]
4. Anti-tumor immunity in breast cancer evaluated by a computerized tube leukocyte adherence inhibition (LAI) assay.
Fink A; Shani A; Feldman B; Wechsler U; Pfeffermann R; Eliraz A; Offer S; Harpaz N; Bentwich Z
Eur J Surg Oncol; 1989 Feb; 15(1):17-9. PubMed ID: 2645173
[TBL] [Abstract][Full Text] [Related]
5. Humoral antitumor immune responses in patients with breast cancer measured with the leukocyte adherence inhibition technique.
Kotlar HK; Sanner T
J Natl Cancer Inst; 1981 Feb; 66(2):265-71. PubMed ID: 7005505
[TBL] [Abstract][Full Text] [Related]
6. An isolated enriched organ-specific cancer neoantigen of human lung cancer for leukocyte adherence inhibition assays.
Dubois AE; Thomson DM; Sutherland ME; Scanzano R
Cancer Res; 1985 Jun; 45(6):2661-9. PubMed ID: 3886136
[TBL] [Abstract][Full Text] [Related]
7. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
Halliday WJ; Koppi TA; Khan JM; Davis NC
J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
[TBL] [Abstract][Full Text] [Related]
8. An overview: antitumor immunity in breast cancer assayed by tube leukocyte adherence inhibition.
Flores M; Marti JH; Grosser N; MacFarlane JK; Thomson DM
Cancer; 1977 Feb; 39(2):494-505. PubMed ID: 319891
[TBL] [Abstract][Full Text] [Related]
9. Effector lymphocyte response to homologous tumor antigens in various stages of malignant disease as monitored by leukocyte adherence inhibition--cell mediated immunity (LAI-CMI).
Tsang PH; Roboz JP; Holland JF; Bekesi JG
Immunol Lett; 1988 Jan; 17(1):63-70. PubMed ID: 3280478
[TBL] [Abstract][Full Text] [Related]
10. Organ specific neoantigens reactive in the leukocyte adherence inhibition assay: affinity purification of human colon carcinoma antigen and its cross-reactive protein using monoclonal antibodies.
Hadas E; Fink A; Gembom E; Harpaz N; Shani A; Bentwich Z; Eshhar Z
Cancer Res; 1986 Oct; 46(10):5201-5. PubMed ID: 2428475
[TBL] [Abstract][Full Text] [Related]
11. Demonstration of the microtest version of the leukocyte adherence inhibition assay.
Goldrosen MH; Howell JH; Holyoke ED
Cancer Res; 1979 Feb; 39(2 Pt 2):630-2. PubMed ID: 367588
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of leukocyte adherence by 3-M potassium chloride extracts of human colorectal tumors.
Ichiki AT; Quirin YP; Collmann IR; Sonoda T; Krauss S
J Natl Cancer Inst; 1980 Mar; 64(3):419-23. PubMed ID: 6986496
[TBL] [Abstract][Full Text] [Related]
13. Specific immunodiagnosis of hepatoma by tube leukocyte adherence inhibition assay and a modified method of repeated tube leukocyte adherence inhibition assay.
Morizane T; Kumagai N; Tsuchimoto K; Watanabe T; Tsuchiya M
Cancer Res; 1980 Aug; 40(8 Pt 1):2928-34. PubMed ID: 6248217
[TBL] [Abstract][Full Text] [Related]
14. Leukocyte adherence inhibition (LAI) for detecting specific tumor immunity in colorectal cancer.
Fink A; Shani A; Weisman Z; Wechsler U; Pfeffermann R; Harpaz N; Eitan S; Bentwich Z
Immunol Lett; 1985; 9(2-3):143-7. PubMed ID: 3886534
[TBL] [Abstract][Full Text] [Related]
15. Specificity of micro-leucocyte adherence inhibition test in patients with gastric cancer.
Koide Y; Wakazono K; Yamagata K; Miyaji M; Yamamoto M
Gan; 1979 Aug; 70(4):541-4. PubMed ID: 92433
[TBL] [Abstract][Full Text] [Related]
16. [Leukocyte-adherence-inhibition reactivity in patients with colorectal and pancreatic cancer (author's transl)].
Wagner T; Peschel U; Heydrich D; Ritter U
Z Gastroenterol; 1981 Mar; 19(3):140-7. PubMed ID: 7234027
[TBL] [Abstract][Full Text] [Related]
17. Human tumor-specific immunity assayed by a computerized tube leukocyte adherence inhibition.
Thomson DM; Tataryn DN; Lopez M; Schwartz R; MacFarlane JK
Cancer Res; 1979 Feb; 39(2 Pt 2):638-43. PubMed ID: 83918
[No Abstract] [Full Text] [Related]
18. The isolation of colon cancer organ specific neoantigen by the use of the leukocyte adherence inhibition assay and monoclonal antibodies.
Fink A; Harpaz N; Weisman Z; Shani A; Bentwich Z
Anticancer Res; 1986; 6(4):813-7. PubMed ID: 3752960
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of the computerized tube leukocyte adherence inhibition (LAI) assay for human colorectal, breast and lung cancers.
Berner Y; Fink A; Shani A; Weisman Z; Eliraz A; Bruderman I; Bentwich Z
Oncology; 1986; 43(5):327-34. PubMed ID: 3531955
[TBL] [Abstract][Full Text] [Related]
20. A coded study of antitumor immunity to human lung cancer assayed by tube leukocyte adherence inhibition.
Thomson DM; Ayeni RO; MacFarlane JK; Tataryn DN; Terrin M; Schraufnagel D; Wilson J; Mulder DS
Ann Thorac Surg; 1981 Apr; 31(4):314-21. PubMed ID: 6260045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]